User banner image
User avatar
  • admin

Posts

Baobab Ingredients Market Revenue to Hit US$ 8.2 Bn by 2031 | Driven by Rising Demand for Functional Foods, Drinks, and Organic Cosmetics – Exclusive Report by Transparency Market Research, Inc.

The global baobab ingredients market is witnessing steady growth, fueled by the rising demand for functional foods, beverages, and organic cosmetics. Key drivers include the...

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year Full year...

Abinopharm, Inc. warmly congratulates partner company EGT Synbio on receiving no objection letter from the FDA for their GRAS notification of Dr.Ergo®Ergothioneine

SHELTON, Conn., March 24, 2025 (GLOBE NEWSWIRE) — Abinopharm, Inc., an innovative nutritional and biopharmaceutical company, is pleased to announce that their partner company, EGT...

e.l.f. Beauty, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights – ELF

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in e.l.f. Beauty, Inc. (“e.l.f. Beauty” or the “Company”) (NYSE: ELF)...

Toll Brothers Announces New Luxury Home Community, Ascente, Now Open in South Reno, Nevada

RENO, Nev., March 24, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its highly anticipated community, Ascente by...

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

DENVER, March 24, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients...

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

HUNTSVILLE, March 24, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization...

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025 BDC-3042 Phase 1 clinical trial fully enrolled the highest dose...

OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana

WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of...

Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and...